Cydan

Cydan

Cydan

Cydan, an orphan drug accelerator dedicated to creating therapies that improve the lives of patients living with rare genetic diseases.
Type
B2b
Founded
2012
Raised
$60M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$10,000,000
Venture capital - 2013
Team Size
2
Employees
Xconomy

Cydan, NEA’s Orphan Drug Experiment, Pays Off in $200M Vtesse Deal

Health
$31,000,000 Venture capital (Series A)
businesswire , FinSMEs

Cydan Development Announces Formation of Imara Inc. with $31M Series A Funding to Develop Therapeutic for Sickle Cell Di...

Xconomy

East Coast Biotech Roundup: Intellia, What’s Hot, Cydan, Fog & More

Science Health
Xconomy

Cydan, NEA’s Orphan Drug Accelerator, Targets Sickle Cell With Startup Imara

Funding Health